Iranian Heart Journal

Iranian Heart Journal

Postoperative Serum Amylase Levels and the Mean Arterial Pressure During Cardiopulmonary Bypass: An Observational Study

Document Type : Original Article

Authors
Rasoul Azarfarin 1
Kambiz Ghasemy 2
Farhad Gorjipour 2
Mohsen Ziyaeifard 1
Ziae Totonchi 1
Naser Kachoeian 3
Meysam Mortazian 4
Alireza Yaghoubi 5
Meysam Mahdavi 1
Jamal Ghadiri 1
1 Cardio-Oncology Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, IR Iran.
2 Iranian Scientific Society of Extracorporeal Technology, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, IR Iran.
3 Department of Cardiac Surgery, Imam Hossein Educational Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran.
4 AJA University of Medical Sciences, Tehran, IR Iran.
5 Department of Cardiac Surgery, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, IR Iran.
Abstract
Background: Postoperative gastrointestinal complications are important in that they lead to increased lengths of hospitalization in the intensive care unit (ICU) and mortality among patients undergoing surgery on cardiopulmonary bypass (CPB). It appears that such gastrointestinal complications may be correlated with the postoperative serum level of amylase among patients. We aimed to determine the relationship between the mean arterial pressure (MAP) during CPB and changes in the postoperative serum level of amylase.
 
Methods: In this observational study, 164 adult patients who underwent cardiac operations and were transferred into the ICU of Rajaie Cardiovascular Medical Research Center (Tehran, Iran) were enrolled via convenience sampling. The patients’ demographic and clinical data, as well as hemodynamic parameters including MAP, were measured during and after CPB in the ICU. Serum amylase levels were assessed after anesthesia induction, after CPB, 12 and 24 hours after CPB.
 
Results: The mean serum level of amylase significantly increased after CPB and continued 24 hours after ICU admission. There was no statistically significant relationship between MAP during CPB and the serum amylase level immediately after CPB and at 12 and 24 hours after ICU admission. A significant relationship was found between gender and age and a serum level of amylase of greater than 125 IU/L at 12 and 24 hours after CPB.
 
Conclusions: The serum level of amylase increased after CPB up to 24 hours following ICU admission. There was no significant relationship between MAP during CPB and the serum amylase level after cardiac surgery. (Iranian Heart Journal 2020; 21(4): 76-84)
 

Highlights

 

 

Keywords
Amylase
Cardiopulmonary bypass
Mean arterial pressure

 

 
  1. Ying L, Liu B, Huang Y. Risk factor analysis for hyperamylasemia after open-heart surgery. Chinese Journal of cardiovascular Rehabilitation Medicine. 2016; 25(5):457-61.
  2. Hulzebos EH, Smit Y, Helders PP, van Meeteren NL. Preoperative physical therapy for elective cardiac surgery patients. Cochrane database of systematic reviews. 2012(11).
  3. Reza Masouleh S, Ahmadi N, Monfared A, Kazem Nejad Leili E. Chest drainage and its associated factors in patients who undergone coronary artery bypass grafting (CABG) surgery and admitted to the intensive care unit (ICU). Journal of Holistic Nursing And Midwifery. 2014; 24(3):10-9.
  4. HUFFMYER JL, GROVES DS. Pulmonary complications of cardiopulmonary bypass.  Best Practice & Research Clinical Anaesthesiology. 292015. p. 163-75.
  5. Gorjipour F, Dehaki MG, Totonchi Z, Hajimiresmaiel SJ, Azarfarin R, Pazoki-toroudi H, et al. Inflammatory cytokine response and cardiac troponin I changes in cardiopulmonary bypass using two cardioplegia solutions; del Nido and modified St. Thomas’: a randomized controlled trial. Perfusion. 2017; 32(5):394-402.
  6. Gorjipour F, Dehaki MG, Totonchi Z, Hajimiresmaiel SJ, Azarfarin R, Pazoki-Toroudi H, et al. Inflammatory cytokine response and cardiac troponin I changes in cardiopulmonary bypass using two cardioplegia solutions; del Nido and modified St. Thomas': a randomized controlled trial. Perfusion. 2017; 32(5):394-402.
  7. Gorjipour F, Hosseini-Gohari L, Alizadeh Ghavidel A, Hajimiresmaiel SJ, Naderi N, Darbandi Azar A, et al. Mesenchymal stem cells from human amniotic membrane differentiate into cardiomyocytes and endothelial-like cells without improving cardiac function after surgical administration in rat model of chronic heart failure. J Cardiovasc Thorac Res. 2019; 11(1):35-42.
  8. Gorjipour F, Totonchi Z, Gholampour Dehaki M, Hosseini S, Tirgarfakheri K, Mehrabanian M, et al. Serum levels of interleukin-6, interleukin-8, interleukin-10, and tumor necrosis factor-α, renal function biochemical parameters and clinical outcomes in pediatric cardiopulmonary bypass surgery. Perfusion. 2019:0267659119842470.
  9. Davidson JA, Urban TT, Baird C, Tong S, Woodruff A, Twite M, et al. Alkaline phosphatase in infant cardiopulmonary bypass: kinetics and relationship to organ injury and major cardiovascular events. The Journal of pediatrics. 2017; 190:49-55. e2.
  10. Hoashi T, Miyata H, Murakami A, Hirata Y, Hirose K, Matsumura G, et al. The current trends of mortality following congenital heart surgery: the Japan Congenital Cardiovascular Surgery Database. Interactive cardiovascular and thoracic surgery. 2015; 21(2):151-6.
  11. Tully PJ, Winefield HR, Baker RA, Denollet J, Pedersen SS, Wittert GA, et al. Depression, anxiety and major adverse cardiovascular and cerebrovascular events in patients following coronary artery bypass graft surgery: a five year longitudinal cohort study. BioPsychoSocial medicine. 2015; 9(1):14.
  12. LIKOSKY DS, PAUGH TA, HARRINGTON SD, WU X, ROGERS MA, DICKINSON TA, et al. Prediction of transfusions after isolated coronary artery bypass grafting surgical procedures. The Annals of thoracic surgery,. 2017; 103:764-72.
  13. Vitale V, Ricci Z, Gaddi S, Testa G, Toma P, Cogo P. Lung ultrasound profile after cardiopulmonary bypass in paediatric cardiac surgery: first experience in a simple cohort. Interactive cardiovascular and thoracic surgery. 2017; 24(4):598-602.
  14. Cholley B, Caruba T, Grosjean S, Amour J, Ouattara A, Villacorta J, et al. Effect of levosimendan on low cardiac output syndrome in patients with low ejection fraction undergoing coronary artery bypass grafting with cardiopulmonary bypass: the LICORN randomized clinical trial. Jama. 2017; 318(6):548-56.
  15. Lannemyr L, Bragadottir G, Krumbholz V, Redfors B, Sellgren J, Ricksten S-E. Effects of cardiopulmonary bypass on renal perfusion, filtration, and oxygenation in patients undergoing cardiac surgery. Anesthesiology: The Journal of the American Society of Anesthesiologists. 2017; 126(2):205-13.
  16. SERRAINO GF, MURPHY GJ. Routine use of viscoelastic blood tests for diagnosis and treatment of coagulopathic bleeding in cardiac surgery: updated systematic review and meta-analysis. BJA: British Journal of Anaesthesia,. 2017; 118:823-33.
  17. ALIGN H. Witch mechanism is effective on the hyperglycemia after coronary artery bypass surgery? Heart lung circulation. 2017; 26:504-8.
  18. GHOSH .S, FALTER.F., PERINO.AC. Priority International Courier: Delivery Guarantees. Cardiopulmonary Bypass2015.
  19. Lippi G, Valentino M, Cervellin G. Laboratory diagnosis of acute pancreatitis: in search of the Holy Grail. Critical reviews in clinical laboratory sciences. 2012; 49(1):18-31.
  20. Bollen TL. Imaging assessment of etiology and severity of acute pancreatitis. Pancreapedia: The Exocrine Pancreas Knowledge Base. 2016.
  21. Ihaya A, Muraoka R, Chiba Y, Kimura T, Uesaka T, Morioka K, et al. Hyperamylasemia and subclinical pancreatitis after cardiac surgery. World journal of surgery. 2001; 25(7):862-4.
  22. Wan S, Arifi AA, Chan CS, Ng CS, Wan IY, Lee TW, et al. Is hyperamylasemia after cardiac surgery due to cardiopulmonary bypass? Asian Cardiovascular and Thoracic Annals. 2002; 10(2):115-8.
  23. Kwun HM, Jung TE, Lee JC, Lee DH, Han SS. Clinical Significances of Hyperamylasemia Following Cardiopulmonary Bypass. Korean J Thorac Cardiovasc Surg. 2000; 33(8):655.
  24. Guler M, Yamak B, Erdogan M, Aydin U, Kul S, Asil R, et al. Risk factors for gastrointestinal complications in patients undergoing coronary artery bypass graft surgery. Journal of cardiothoracic and vascular anesthesia. 2011; 25(4):637-41.
  25. Hashemzadeh K, Hashemzadeh S, Dehghani M. Risk factors and outcomes of acute renal failure after open cardiac surgery. Asian Cardiovasc Thorac Ann. 2012; 20:275-80.

 

Iranian Heart Journal
Volume 21, Issue 4
Autumn 2020
Pages 65-73